Article
Stroma-targeting strategies in pancreatic cancer: Past lessons, challenges and prospects
10 May 2021
Abstract excerpt
Pancreatic ductal adenocarcinoma (PDAC) is projected to emerge as the second leading cause of cancer-related death after 2030. Extreme treatment resistance is perhaps the most significant factor that underlies the poor prognosis of PDAC. To date, combination chemotherapy remains the mainstay of treatment for most PDAC patients. Compared to other cancer types, treatment response of PDAC tumors to similar...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
